Paeonol promotes the phagocytic ability of macrophages through confining HMGB1 to the nucleus

Jifei Miao1, Peng Ye1, Jiao Lan2

  • 1Research Center of Integrative Medicine, School Basic Medical sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.

Insights

Paeonol enhances macrophage phagocytosis by retaining High Mobility Group Protein B1 (HMGB1) in the nucleus. This action supports immune defense by boosting the cell

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Phagocytosis is a critical immune mechanism against pathogens.
  • Immunosuppression in diseases like sepsis and cancer impairs phagocytic function.
  • High Mobility Group Protein B1 (HMGB1) is implicated in phagocytosis, but its role is debated.

Purpose of the Study:

  • To investigate the effect of paeonol on macrophage phagocytosis.
  • To elucidate the mechanism by which paeonol influences phagocytosis, focusing on HMGB1.

Main Methods:

  • In vivo and in vitro experiments were conducted.
  • Macrophage phagocytic function was assessed using zymosan.
  • The cellular localization of HMGB1 and its interaction with P53 and Focal Adhesion Kinase (FAK) were examined.

Main Results:

  • Paeonol was found to promote macrophage phagocytosis.
  • This effect was mediated by confining HMGB1 to the nucleus.
  • Nuclear HMGB1 interacts with P53, reducing its inhibitory effect on FAK phosphorylation, leading to enhanced pseudopod formation.

Conclusions:

  • Paeonol enhances the phagocytic capacity of macrophages.
  • The mechanism involves the nuclear retention of HMGB1, which positively regulates FAK phosphorylation and cell motility.
  • Paeonol shows potential as an immunomodulatory agent.